Eli Lilly's experimental diabetes drug cut weight by 17% in a study Mar 19, 2026 · Cris Tolomia Eli Lilly's experimental drug retatrutide helped Type 2 diabetes patients lose up to 16.8% of their body weight in a Phase 3 trial, topping all rivals Read more »